These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37881428)

  • 21. SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction.
    Fan R; He H; Yao W; Zhu Y; Zhou X; Gui M; Lu J; Xi H; Deng Z; Fan M
    DNA Cell Biol; 2018 Feb; 37(2):126-132. PubMed ID: 29271667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TMEM196 inhibits lung cancer metastasis by regulating the Wnt/β-catenin signaling pathway.
    Chen J; Wang D; Chen H; Gu J; Jiang X; Han F; Cao J; Liu W; Liu J
    J Cancer Res Clin Oncol; 2023 Feb; 149(2):653-667. PubMed ID: 36355209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin Enhanced Anti-tumor Effects of Bevacizumab against Lung Adenocarcinoma A549 Cells
    Tu X; Zhang J; Yuan W; Wu X; Xu Z; Qing C
    Anticancer Agents Med Chem; 2023; 23(19):2083-2094. PubMed ID: 37587804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of DSTYK activates Wnt/β-catenin signaling and glycolysis in lung adenocarcinoma.
    Zhong C; Chen M; Chen Y; Yao F; Fang W
    Cell Death Dis; 2021 Dec; 12(12):1122. PubMed ID: 34853310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propofol and Sevoflurane Alleviate Malignant Biological Behavior and Cisplatin Resistance of Xuanwei Lung Adenocarcinoma by Modulating the Wnt/β-catenin Pathway and PI3K/AKT Pathway.
    Quan Y; Li S; Wang Y; Liu G; Lv Z; Wang Z
    Anticancer Agents Med Chem; 2022; 22(11):2098-2108. PubMed ID: 35152870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
    Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
    Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of 2-(isoxazol-5-yl)phenyl 3,4-dihydroxybenzoate as a potential inhibitor for the Wnt/β-catenin pathway.
    Dong Y; Liu M; Mao Y; Wu S; Wen J; Lu J; Yang Y; Ruan S; Li L; Liu X; Zhang J; Liao S; Dong L
    Bioorg Chem; 2022 Nov; 128():106116. PubMed ID: 36063753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carnosic acid nanocluster-based framework combined with PD-1 inhibitors impeded tumorigenesis and enhanced immunotherapy in hepatocellular carcinoma.
    Wu W; Li Y; Wu X; Liang J; You W; He X; Feng Q; Li T; Jia X
    Funct Integr Genomics; 2024 Jan; 24(1):5. PubMed ID: 38182693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway.
    Yao Y; Hua Q; Zhou Y
    Biochem Biophys Res Commun; 2019 Jan; 508(1):37-45. PubMed ID: 30470570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy.
    Bi Y; Jiang Y; Li X; Hou G; Li K
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):499-505. PubMed ID: 33225417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMEK1 promotes lung adenocarcinoma proliferation and invasion by activating Wnt/β-catenin signaling pathway.
    Chen D; Gao S; Gao F; Liu A; Li J; Li J; Liu Q
    Clin Transl Oncol; 2023 Apr; 25(4):976-986. PubMed ID: 36463369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.
    Li J; Chen X; Ding X; Cheng Y; Zhao B; Lai ZC; Al Hezaimi K; Hakem R; Guan KL; Wang CY
    Cell Rep; 2013 Dec; 5(6):1650-63. PubMed ID: 24360964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition.
    Hou S; Tian T; Qi D; Sun K; Yuan Q; Wang Z; Qin Z; Wu Z; Chen Z; Zhang J
    Cell Death Dis; 2018 Feb; 9(3):277. PubMed ID: 29449540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
    Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
    Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin pathway.
    Wang Z; Fang Z; Chen G; Liu B; Xu J; Li F; Li F; Liu H; Zhang H; Sun Y; Tian G; Chen H; Xu G; Zhang L; Hu L; Ji H
    Neoplasia; 2021 Feb; 23(2):222-233. PubMed ID: 33387960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
    Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
    Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1.
    Gao J; Zhao C; Liu Q; Hou X; Li S; Xing X; Yang C; Luo Y
    J Exp Clin Cancer Res; 2018 Dec; 37(1):317. PubMed ID: 30547803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.
    Zhan P; Zhang B; Xi GM; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu QQ; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Qian LP; Lv TF; Song Y
    Mol Cancer; 2017 Jun; 16(1):108. PubMed ID: 28646916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
    Yang M; Han YM; Han Q; Rong XZ; Liu XF; Ln XY
    J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.